Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early Notification Helping to Resolve Drug Shortages

This article was originally published in The Gold Sheet

Executive Summary

Despite a growing number of shortages, FDA has helped to prevent many more through its early notification program. An agency official predicted that shortages will be fewer this year thanks to combined FDA and industry efforts and intervention strategies.

You may also be interested in...



FDA Drug Shortage Advice: Talk To Us Early; We’ll Be Discreet

Manufacturers shouldn’t be afraid to work with FDA on preventing drug shortages for fear of public shaming, agency says.

FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin

The 11-member staff CDER devotes to drug shortages is moving to the Office of the Center Director and will report to Deputy Director for Regulatory Programs Doug Throckmorton.

US Supply Chain In Brief: White House Aims To Deliver With Block Stowing And Industrial Base Expansion

Biden administration works to expedite medical supplies and expand medical countermeasures production, while US FDA's DSCSA anti-counterfeiting paperwork burden estimate surges.

UsernamePublicRestriction

Register

PS000651

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel